Concepts (93)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Atherosclerosis | 4 | 2022 | 153 | 0.490 |
Why?
|
| Patient Acuity | 1 | 2021 | 23 | 0.360 |
Why?
|
| Triage | 1 | 2021 | 129 | 0.330 |
Why?
|
| Macrophages | 4 | 2022 | 1041 | 0.290 |
Why?
|
| Monocytes | 3 | 2022 | 353 | 0.290 |
Why?
|
| Emergency Medical Services | 1 | 2021 | 271 | 0.280 |
Why?
|
| Fluorodeoxyglucose F18 | 2 | 2017 | 98 | 0.250 |
Why?
|
| Positron-Emission Tomography | 2 | 2017 | 208 | 0.240 |
Why?
|
| Mass Screening | 1 | 2021 | 692 | 0.240 |
Why?
|
| Ichthyosis | 1 | 2024 | 8 | 0.220 |
Why?
|
| Glutaredoxins | 2 | 2022 | 2 | 0.210 |
Why?
|
| Lipoproteins, LDL | 2 | 2021 | 46 | 0.200 |
Why?
|
| Fresh Water | 1 | 2022 | 12 | 0.190 |
Why?
|
| Microbiota | 1 | 2024 | 129 | 0.190 |
Why?
|
| Fishes | 1 | 2022 | 21 | 0.180 |
Why?
|
| Protective Agents | 1 | 2022 | 12 | 0.180 |
Why?
|
| Proteasome Inhibitors | 1 | 2021 | 32 | 0.170 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 197 | 0.160 |
Why?
|
| Women | 1 | 2019 | 44 | 0.150 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2019 | 76 | 0.150 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2019 | 65 | 0.150 |
Why?
|
| Deoxyglucose | 1 | 2017 | 32 | 0.140 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2017 | 33 | 0.130 |
Why?
|
| Oxidative Stress | 2 | 2022 | 297 | 0.130 |
Why?
|
| Attitude to Health | 1 | 2019 | 293 | 0.130 |
Why?
|
| Glutamine | 1 | 2017 | 48 | 0.130 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 2016 | 32 | 0.130 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2016 | 4 | 0.130 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2016 | 72 | 0.130 |
Why?
|
| Glucose | 2 | 2016 | 468 | 0.120 |
Why?
|
| Multiple Myeloma | 1 | 2021 | 347 | 0.120 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 175 | 0.120 |
Why?
|
| Inflammation | 2 | 2024 | 1146 | 0.110 |
Why?
|
| 14-3-3 Proteins | 1 | 2014 | 19 | 0.110 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2019 | 762 | 0.110 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 2014 | 62 | 0.110 |
Why?
|
| Obesity | 1 | 2022 | 1234 | 0.100 |
Why?
|
| HIV Infections | 1 | 2019 | 972 | 0.090 |
Why?
|
| Medical Staff, Hospital | 1 | 2021 | 62 | 0.090 |
Why?
|
| Vietnam | 2 | 2022 | 173 | 0.080 |
Why?
|
| Electronic Health Records | 1 | 2021 | 367 | 0.070 |
Why?
|
| Oxidation-Reduction | 2 | 2022 | 326 | 0.070 |
Why?
|
| Prevalence | 1 | 2021 | 1383 | 0.070 |
Why?
|
| Mice | 5 | 2022 | 10863 | 0.070 |
Why?
|
| Aorta | 2 | 2017 | 110 | 0.060 |
Why?
|
| Animals | 6 | 2022 | 20715 | 0.060 |
Why?
|
| Receptors, LDL | 2 | 2016 | 34 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2024 | 243 | 0.050 |
Why?
|
| Cells, Cultured | 2 | 2016 | 2166 | 0.050 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 5468 | 0.040 |
Why?
|
| Phenotype | 2 | 2016 | 1208 | 0.040 |
Why?
|
| Lipid Peroxides | 1 | 2021 | 11 | 0.040 |
Why?
|
| Boron Compounds | 1 | 2021 | 20 | 0.040 |
Why?
|
| Glycine | 1 | 2021 | 49 | 0.040 |
Why?
|
| Bortezomib | 1 | 2021 | 56 | 0.040 |
Why?
|
| Granulocytes | 1 | 2021 | 71 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2024 | 1120 | 0.040 |
Why?
|
| Reactive Oxygen Species | 1 | 2022 | 225 | 0.040 |
Why?
|
| Oligopeptides | 1 | 2021 | 132 | 0.040 |
Why?
|
| Middle Aged | 2 | 2021 | 17656 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2021 | 6619 | 0.040 |
Why?
|
| Humans | 5 | 2024 | 63527 | 0.040 |
Why?
|
| Transcriptome | 1 | 2022 | 386 | 0.040 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 2196 | 0.030 |
Why?
|
| Autoradiography | 1 | 2017 | 53 | 0.030 |
Why?
|
| Socioeconomic Factors | 1 | 2019 | 784 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2021 | 1470 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 1 | 2016 | 202 | 0.030 |
Why?
|
| Radiopharmaceuticals | 1 | 2016 | 190 | 0.030 |
Why?
|
| Aged | 1 | 2021 | 14451 | 0.030 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 3401 | 0.030 |
Why?
|
| Lim Kinases | 1 | 2014 | 3 | 0.030 |
Why?
|
| Actin Depolymerizing Factors | 1 | 2014 | 4 | 0.030 |
Why?
|
| Chemokine CCL2 | 1 | 2014 | 57 | 0.030 |
Why?
|
| Glutathione | 1 | 2014 | 54 | 0.030 |
Why?
|
| Phosphoprotein Phosphatases | 1 | 2014 | 41 | 0.030 |
Why?
|
| Female | 3 | 2022 | 32939 | 0.030 |
Why?
|
| Proteolysis | 1 | 2014 | 146 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2019 | 2584 | 0.020 |
Why?
|
| Transfection | 1 | 2014 | 695 | 0.020 |
Why?
|
| Pregnancy | 1 | 2019 | 2335 | 0.020 |
Why?
|
| HEK293 Cells | 1 | 2014 | 622 | 0.020 |
Why?
|
| Phosphorylation | 1 | 2014 | 937 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2019 | 2702 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2016 | 1356 | 0.020 |
Why?
|
| Child | 1 | 2019 | 4541 | 0.020 |
Why?
|
| Young Adult | 1 | 2019 | 4714 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2014 | 2113 | 0.020 |
Why?
|
| Adolescent | 1 | 2019 | 6259 | 0.020 |
Why?
|
| Male | 2 | 2022 | 29931 | 0.020 |
Why?
|
| Time Factors | 1 | 2014 | 3708 | 0.020 |
Why?
|
| Mutation | 1 | 2014 | 2615 | 0.010 |
Why?
|
| Adult | 1 | 2019 | 16895 | 0.010 |
Why?
|